Here’s the proof it works
Tens of thousands of patients worldwide rely on Boston Scientific technology for relief from pain. The effectiveness of Boston Scientific pain management solutions has also been proven in a number of important clinical studies and trials.
Spinal Cord Stimulation (SCS)
Significant Long-Term Relief
In a major clinical study, back pain patients reported a nearly 6-point drop in pain score, even after two years.1
Tens of thousands of people across the globe look to Boston Scientific SCS therapy for long-term, drug-free, FDA-approved pain relief.
More than 90% of Boston Scientific SCS trial participants reported a successful experience and opted to get the permanent implant.2
9 out of 10 Boston Scientific SCS patients said they were satisfied with their therapy and 95% would recommend it to others.2
The minimally invasive Vertiflex Procedure is FDA approved and backed by a long-term clinical study.
Over 20,000 patients have received pain relief from the Vertiflex Procedure since FDA approval.
In the clinical study, most patients on opioids stopped using them after the Vertiflex Procedure.3,*
Nine out of ten patients in the clinical study were satisfied with their pain relief and increase in physical activity.4,‡
Radiofrequency Ablation (RFA)
Studies show that more than 70% of patients treated with RFA experience relief—lasting anywhere from six to 12 months, and in some cases, years.5-7
Real patient stories
See how people just like you discovered their own personal relief from pain and rejoined their lives.
Wondering which of our pain management solutions may be right for you?
Take this quick quiz and find out. ⟶
†Superion™ Indirect Decompression System.
*Decrease in the proportion of patients using opioids compared to baseline at five years.
References: 1. Veizi E, Hayek SM, North J, et al. Spinal cord stimulation (SCS) with anatomically guided (3D) neural targeting shows superior chronic axial low back pain relief compared to traditional SCS—LUMINA Study. Pain Med. 2017;18(8):1534-1548. 2. Thomson SJ, Kruglov D, Duarte RV. A spinal cord stimulation service review from a single centre using a single manufacturer over a 7.5 year follow-up period. Neuromodulation. 2017;20(6):589-599. N=321 3. Nunley PD, Deer TR, Benyamin RM, Staats PS, Block JE. Interspinous process decompression is associated with a reduction in opioid analgesia in patients with lumbar spinal stenosis. J Pain Res. 2018;11:2943-2948. 4. Nunley PD, Patel VV, Orndorff DG, Lavelle WF, Block JE, Geisler FH. Five-year durability of stand-alone interspinous process decompression for lumbar spinal stenosis. Clin Interv Aging. 2017;12:1409-1417. N=88 5. MacVicar J, Borowczyk JM, MacVicar AM, Loughnan BM, Bogduk N. Cervical medial branch radiofrequency neurotomy in New Zealand. Pain Med. 2012;13(5):647-654. 6. Dreyfuss P, Halbrook B, Pauza K, Joshi A, McLarty J, Bogduk N. Efficacy and validity of radiofrequency neurotomy for chronic lumbar zygapophysial joint pain. Spine. 2000;25(10):1270-1277. 7. Govind J, King W, Bailey B, Bogduk N. Radiofrequency neurotomy for the treatment of third occipital headache. J Neurol Neurosurg Psychiatry. 2003;74(1):88-93.
Results from clinical studies are not predictive of results in other studies. Results in other studies may vary.